The Disruptive Power of Pharma AI
In the first of the Pharma Integrates Insights series, Marco Mohwinckel examines the adoption of artificial intelligence (AI) by pharmaceutical companies and sheds some light on what’s real … and what’s yet to come
Revolutionising Drug Discovery with Big Data and AI
As terabytes of healthcare data are generated that are more easily accessible to a broader range of stakeholders, Marco Mohwinckel examines whether a new age of AI-driven drug discovery is just around the corner
If you’re in #genomics, you know the challenges of complex biological data.
@Biomatics_uk have launched a new service offering experienced & flexible resources to support your project.
From academia to consultancy services & genomics delivery, learn more:
https://www.lifescienceintegrates.com/data-solutions-in-genomics/
The no. of people diagnosed with #cancer could increase by 18% in 2040. Prevention, detection, diagnosis & treatments are improving, but there's still lots to do. Ahead of #WorldCancerDay tomorrow, watch ‘the Big C’ panel discussion from #PharmaIntegrates
https://player.vimeo.com/video/772550592?h=6a6380832a&dnt=1&app_id=122963
Last #February, we held our first #PharmaSustainabilityIntegrates with @ukCPI, @ABPI_UK & @UniStrathclyde
As a unique forum for leaders in #Pharma & #policy to discuss how to take #COP26 forward, it’s a chance to look at how far we’ve come in a year:
https://www.lifescienceintegrates.com/101-days-from-cop26-life-sciences-lead-the-way-to-decarbonisation-at-pharma-sustainability-integrates/